Informing Patients About Expected Outcomes: The Efficacy-Effectiveness Gap-Reference-Cited by-同舟云学术

Informing Patients About Expected Outcomes: The Efficacy-Effectiveness Gap

Published:2020-05-20 Issue:15 Volume:38 Page:1651-1654
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Templeton Arnoud J.¹,Booth Christopher M.²,Tannock Ian F.³

Affiliation:

1. Department of Medical Oncology, St Claraspital Basel, and Faculty of Medicine, University of Basel, Basel, Switzerland

2. Division of Cancer Care and Epidemiology, Queen’s University Cancer Research Institute, Kingston, Ontario, Canada

3. Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JCO.19.02035

Reference26 articles.

1. External validity of randomised controlled trials: “To whom do the results of this trial apply?”

2. A literature review on the representativeness of randomized controlled trial samples and implications for the external validity of trial results

3. Comparison of treatment outcome in metastatic colorectal cancer patients included in a clinical trial versus daily practice in The Netherlands

4. Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials

5. Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving sustainability of a patient decision aid for systemic treatment of metastatic colorectal cancer: A qualitative study;PEC Innovation;2024-12

2. Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months;European Journal of Cancer;2024-09

3. A novel framework to assess haematology and oncology registration trials: The THEOREMM project;European Journal of Clinical Investigation;2024-06-27

4. Study Participants, Future Patients, and Outcomes That Matter in Cancer Clinical Trials;JAMA;2024-06-25

5. Survival Benefit Associated With Participation in Clinical Trials of Anticancer Drugs;JAMA;2024-06-25